Skip to main content

Table 3 Coverage estimates and confidence intervals by IRS type

From: Retrospective evaluation of the effectiveness of indoor residual spray with pirimiphos‐methyl (Actellic) on malaria transmission in Zambia

Coverage estimate 2014 2015 2016
Operational coverage
IRS 94.7 (93.6–95.9) 94.3 (93.2–95.4) 92.4 (91.4–93.4)
IRS with mSpray 87.0 (83.5–90.5) 95.0 (93.8–96.3) 88.8 (87.4–90.1)
Structures per population
IRS 0.13 (0.11–0.14) 0.17 (0.15–0.18) 0.17 (0.15–0.20)
IRS with mSpray 0.14 (0.11–0.17) 0.19 (0.14–0.23) 0.21 (0.16–0.25)